|
|
Binance |
|
|
Coinbase |
|
|
KUCOIN |
|
|
AscendEX (Formally BitMax) |
By Trader Edge at 2026-09-24 05:57
Sentiment: Negative
TLDR Moderna stock jumped over 14% after its personalized mRNA cancer vaccine, intismeran autogene, hit its primary goal in a Phase 3 trial The trial showed intismeran, combined with Merck’s Keytruda, helped melanoma patients stay cancer-free longer than Keytruda alone Barclays raised its price target on Moderna to $125 from $48; Wolfe Research upgraded the [...] The post Is Moderna (MRNA) Stock a Buy After the Cancer Vaccine Breakthrough? appeared first on CoinCentral. Continue reading...
Categories: Stocks
Tags: #Stocks
Source Coin Central